• No results found

University of Groningen End-Stage Renal Disease Related Hyperparathyroidism van der Plas, Willemijn

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen End-Stage Renal Disease Related Hyperparathyroidism van der Plas, Willemijn"

Copied!
10
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

End-Stage Renal Disease Related Hyperparathyroidism

van der Plas, Willemijn

DOI:

10.33612/diss.151471102

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2021

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

van der Plas, W. (2021). End-Stage Renal Disease Related Hyperparathyroidism: Towards a Patient-Tailored Journey. University of Groningen. https://doi.org/10.33612/diss.151471102

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

End-Stage Renal Disease Related Hyperparathyroidism:

Towards a Patient-Tailored Journey

(3)

van der Plas, Willemijn Ytje

End-Stage Renal Disease Related Hyperparathyroidism: Towards a Patient-Tailored Journey

Design: Willemijn van der Plas

Printed by: Ridderprint - www.ridderprint.nl

The printing of this thesis was financially supported by Universitair Medisch Centrum Groningen, Graduate School of Medical Sciences, Nederlandse Transplantatie Vereniging, and Chipsoft.

© 2021 W.Y. van der Plas, Groningen, the Netherlands. All rights reserved. No part of this the-sis may be reproduced, stored in retrieval systems, or transmitted in any form by any me-ans, electronic, mechanical, photocopying, recording or otherwise without the prior writ-ten permission of the author or, when appropriate, of the publisher of the published articles.

(4)

End-Stage Renal Disease Related Hyperparathyroidism:

Towards a Patient-Tailored Journey

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. C. Wijmenga en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 3 februari 2021 om 16.15 uur

door

Willemijn Ytje van der Plas geboren op 3 september 1994

(5)

Promotores

Prof. dr. G.M. van Dam Prof. dr. M.H. de Borst Compromotores Dr. S. Kruijff Dr. A.F. Engelsman Beoordelingscommissie Prof. dr. G.J. Navis Prof. dr. M.G. Vervloet Prof. dr. M.R. Vriens

(6)

Paranimfen S. Benjamens C.E. Vollenbrock

(7)
(8)

Ode aan de tijd

De tijd verstrijkt tot eeuwigheid Dat is voorwaar geen kleinigheid Want, mocht de wereld ooit vergaan De tijd zal steeds blijven bestaan Hij was er al voor het begin En gaat mee het oneindig in Wanneer ge meent: “er is geen tijd” Ontkent ge de realiteit Want alle leven, elk bestaan Kan door de tijd slechts verder gaan Een regelmaat verraadt zijn aard ‘t Is nooit te vroeg, laat staan te laat Al lijkt de tijd soms stil te staan Toch blijkt hij te zijn doorgegaan Soms schijnt hij zoek (waar blijft de tijd?) Toch is hij er in werk’lijkheid Een schijn van ongeregelheid Verblindt de geest, ‘ t verstand ten spijt De geest is bezig met de daad Terwijl de tijd stil verder gaat... De tijd schrijdt voort, heel ongestoord Beidt gij hem wel zo het behoort?

Ytje Minderhoud - Brouwer (Oma Ytje) Wageningen, december 1981

(9)

Table of contents

Chapter 1 General introduction and outline of the thesis 10

Part I: End-stage renal disease related hyperparathyroidism

Chapter 2 Secondary and tertiary hyperparathyroidism

– a narrative review

28

Chapter 3 Association of time-updated plasma calcium and phosphate

with graft and patient outcomes after kidney transplantation 46

Part II: Surgical treatment for ESRD-related HPT

Chapter 4 Safety and efficacy of subtotal or total parathyroidectomy for

patients with secondary or tertiary hyperparathyroidism in four academic centers in the Netherlands

82

Chapter 5 Timing of parathyroidectomy does not influence renal function

after kidney transplantation

98

Chapter 6 Quality of life after surgery in secondary hyperparathyroidism,

comparing subtotal parathyroidectomy with total parathyroid-ectomy with immediate parathyroid autograft

– a prospective randomized trial

116

Chapter 7 Parathyroidectomy for patients with secondary

hyperparathy-roidism in a changing landscape for the management of end-stage renal disease

(10)

Part III: Evaluation of the role of parathyroidectomy and calcimimetics in a changing treatment algorithm of ESRD-related HPT

Chapter 8 Effect of parathyroidectomy and cinacalcet on quality of life in

patients with end-stage renal disease-related hyperparathy-roidism

– a systematic review

156

Chapter 9 Outcomes of parathyroidectomy versus calcimimetics for

sec-ondary hyperparathyroidism and kidney transplantation – a propensity matched analysis

174

Chapter 10 Impact of the introduction of calcimimetics on timing of para-thyroidectomy in secondary and tertiary hyperparathyroidism

192

Chapter 11 Treatment strategy of end-stage renal disease related

hyper-parathyroidism before, during and after the era of calcimimetics

210

Chapter 12 Changing landscape of the treatment of hyperparathyroidism related to end-stage renal disease

– can we turn the clock backward?

230

Chapter 13 Summary and general discussion Future perspectives 236 Chapter 14 Appendices 250 254 264 268 272 279 Dutch summary – Nederlandse samenvatting

List of contributing authors List of publications

Acknowledgements - Dankwoord Curriculum Vitae

Referenties

GERELATEERDE DOCUMENTEN

In the long-term, end-stage renal disease patients with hyperparathyroidism have an increased risk of all-cause and cardiovascular mortality.. Among treatment options are

latest update of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease – Mineral and Bone Disorder (CKD-MBD) guideline recommends cinacalcet even as a first

‡ The above model adjusted for donor type, donor age and sex, total number of HLA mismatches, pre- transplant dialysis status (pre-emptive or dialysis), cold

Because we observed no significant difference when the comparing results of the SF-36 survey scores of the three surgical approaches, our results indicate the type of operation does

After one year of follow-up, serum corrected calcium levels were still significantly improved compared to preopera- tively in the subtotal PTx group and the total PTx group

Patients with end-stage renal disease (ESRD) have a decreased quality of life (QoL), which is in part attributable to ESRD-related hyperparathyroidism (HPT).. Both cinacalcet and

In conclusion, PTx prior to KTx resulted in significantly fewer severe KTx related complications compared to patients treated with calcimimetics while graft survival and

The study population of this retrospective, single-center study consisted of all ESRD patients with secondary or tertiary HPT who underwent PTx and were aged 18 years and